All Medical Microbiology articles – Page 5
-
NewsMeasles vaccine gaps persist among ER patients
A study has found critical gaps in knowledge, vaccination status, and acceptance of the measles, mumps, and rubella (MMR) vaccine among patients visiting emergency departments across the United States. It examines how misinformation and access barriers may contribute to declining vaccination rates.
-
NewsStudy finds blood pressure drug effective for treating antibiotic-resistant bacteria
A new study reports that a drug used to lower blood pressure could also be the basis of a promising new treatment for methicillin-resistant Staphylococcus aureus (MRSA). Candesartan cilexetil not only killed MRSA bacteria at different growth stages, but also reduced the formation of biofilms.
-
NewsModeling premature aging in yeast reveals key effects of progerin on cellular lifespan
Researchers developed a yeast-based model to study premature aging by expressing Progerin, the toxic protein responsible for Hutchinson–Gilford Progeria Syndrome. Using genetically engineered yeast cells, they compared the effects of Progerin with its normal counterpart, Lamin A.
-
NewsLong-term cure rates for multidrug-resistant tuberculosis much better than expected
A new national cohort study from Latvia provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB). The study shows that long-term disease-free survival rates are significantly higher than previous standard indicators suggest.
-
NewsGlobal strategy to combat drug‑resistant fungi is about to change
An increasing number of fungi are becoming resistant to medication, posing serious risks for patients with weakened immune systems. That is why fifty researchers from around the world are calling for action against drug‑resistant fungi.
-
NewsUltrasensitive test reveals evidence of previously undetected tuberculosis in Boston Hospital patients
Researchers have discovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA (TB DNA) in patients hospitalized in Boston, suggesting that tuberculosis disease may be significantly underdiagnosed in the United States.
-
NewsShorter antibiotic courses show similar outcomes to longer use for some pneumonia patients
A multicenter target trial emulation found that for eligible patients hospitalized with community-acquired pneumonia (CAP), health outcomes were similar whether they received a three- to four-day course of antibiotics or a course lasting five days or more.
-
NewsImmunogenicity and safety of an Escherichia coli-produced 9-valent HPV vaccine in adolescents compared with young women
Based on new findings, the National Medical Products Administration of China has approved a two-dose immunization schedule for the domestically produced 9-valent HPV vaccine in girls aged 9 to 17 years.
-
NewsNovel treatment protocol targets the deadliest cases of C. difficile infection
A new study demonstrated that fecal microbiota transplantation (FMT) can rapidly reverse systemic inflammation and improve survival in patients with fulminant Clostridioides difficile infection.
-
NewsCharacteristics of CD4+T-cell reduction and pulmonary infections in critically ill immunocompromised patients
A new study investigates the relationship between reduced CD4+T-cell counts and lung infections in immunosuppressed patients admitted to intensive care units (ICUs).
-
NewsInterferon therapy found to be well-tolerated in compensated hepatitis B cirrhosis
A multicenter analysis of 920 patients finds no higher risk of serious complications in compensated cirrhosis compared to standard treatment.
-
NewsLong COVID associated with increased risk of cardiovascular disease
People with long COVID are at increased risk of developing cardiovascular disease, according to a new study. Women with long COVID had just over twice the risk of receiving a cardiovascular diagnosis compared with women without long COVID. Men had approximately a third higher risk.
-
NewsCall for evidence: Why has the promise of personalised medicine failed to materialise on the ground?
A new inquiry by the UK Parliament’s Science and Technology Committee investigates why the NHS adoption of the UK’s cutting-edge life sciences innovations often fails - and what could be done to fix it. Members of AMI could be just the people to provide answers.
-
NewsDramatic reduction in prescribing of hepatitis C antivirals may leave many curable patients untreated
A new study analyzed a large national prescription database to estimate hepatitis C treatment courses over time and trends by patient and prescriber characteristics from 2013–2025. Prescriptions rose rapidly after direct-acting antivirals first became available, peaking in 2015, but then declined sharply through 2025.
-
NewsSimple antiseptic can reduce newborn infections
A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle-income countries, and may reduce newborn deaths.
-
NewsWhy is vaccination for target populations plummeting in the UK? Share your insights!
As a group of leading UK health experts launches a new Commission on Access to Vaccines to understand why access levels are falling across the UK, Applied Microbiology International is calling on members to share their insights on childhood vaccinations.
-
NewsStudy details neuropsychiatric symptoms and biological mechanisms of long COVID
A review highlights the need to standardize diagnosis and treatment of long Covid. In the study, the researchers emphasize that avoiding SARS-CoV-2 infection is the only way to prevent long COVID so far.
-
NewsSmart wound dressing delivers antibiotics on-demand, accelerating healing and reducing resistance
Biomedical engineers have developed a new wound dressing material that releases antibiotic drugs only when harmful bacteria are present in a wound. The material could help rapidly clear wound infections to accelerate healing while reducing the unnecessary use of antibiotics.
-
NewsWebinar: Unraveling periprosthetic joint infection
The free ‘Unraveling Periprosthetic Joint Infection’ webinar on March 25 explores one of the most challenging complications in modern orthopedic medicine, sitting at the intersection of microbiology, surgery, and patient care.
-
NewsDengue vaccine remains 80.5% effective against severe cases after five years
The tetravalent dengue vaccine was 80.5% effective against severe dengue cases with warning signs over a five-year period. Overall, the vaccine was 65% effective in preventing symptomatic dengue (caused by any serotype) during the five years of monitoring.